A
Ana I. García-Pérez
Researcher at University of Alcalá
Publications - 18
Citations - 400
Ana I. García-Pérez is an academic researcher from University of Alcalá. The author has contributed to research in topics: Apoptosis & Dequalinium. The author has an hindex of 11, co-authored 18 publications receiving 360 citations.
Papers
More filters
Journal ArticleDOI
Molecular Crowding and Viscosity as Determinants of Translational Diffusion of Metabolites in Subcellular Organelles
Ana I. García-Pérez,Emilio A. López-Beltrán,Peter Klüner,José Luque,Paloma Ballesteros,Sebastián Cerdán +5 more
TL;DR: Investigation of subcellular organelles using the pulse-field gradient spin-echo 1H NMR technique reveals important differences in molecular crowding within the different sub cellular compartments, suggesting considerable diffusional heterogeneity for small metabolites within theDifferent intracellular organells.
Journal ArticleDOI
Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production.
TL;DR: DQA-induced NB4 and K562 cell alterations are initiated within the first 30 min of treatment at a high DQA concentration with a mitochondrial membrane depolarization, and apoptosis by a typical caspase-9/caspase3-dependent intrinsic pathway is induced.
Journal ArticleDOI
Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines. Mitochondrial implication in cell death.
Eva Galeano,Elena Nieto,Ana I. García-Pérez,M. Dolores Delgado,Montserrat Pinilla,Pilar Sancho +5 more
TL;DR: New knowledge is improved on DQA as a novel anticancer agent with a potential application in human acute promyelocytic leukemia chemotherapy and cell death seems to be mediated by alterations of mitochondrial function.
Journal ArticleDOI
Different roles of Nrf2 and NFKB in the antioxidant imbalance produced by esculetin or quercetin on NB4 leukemia cells
TL;DR: Data support a relevant differential role for NFkB and Nrf2 in anti-inflammatory and redox response when apoptosis was induced by esculetin or quercetin in human leukemia NB4 cells.
Journal ArticleDOI
In vivo biodistribution of erythrocytes and polyethyleneglycol-phosphatidylethanolamine micelles carrying the antitumour agent dequalinium.
Carmen Lizano,Volkmar Weissig,Vladimir P. Torchilin,Pilar Sancho,Ana I. García-Pérez,Montserrat Pinilla +5 more
TL;DR: Dequalinium, a lipophilic drug with anti-cancer activity has been incorporated into mouse red blood cells and polyethylene glycol phosphatidylethanolamine micelles in order to overcome the drug's solubility problems and to make it suitable for in vivo applications.